AFRO-NETS> Adverse effects of mefloquine: due to primary liver damage?

[Andrew Herxheimer <andrew_herxheimer@CompuServe.COM>]

Adverse effects of mefloquine: due to primary liver damage?
-----------------------------------------------------------

Source: E-Drug <e-drug@usa.healthnet.org>

Ashley Croft and I have just published a paper in BiomedCentral Pub-
lic Health (a freely accessible electronic journal), in which we sug-
gest the hypothesis that many of the adverse effects of mefloquine 
are due to modest liver damage, possibly with secondary thyroid in-
volvement. The hypothesis needs testing, and meanwhile it seems ad-
visable to revise the contra-indications and warnings for the use of 
mefloquine.

The URL is:
http://www.biomedcentral.com/1471-2458/2/6

Andrew Herxheimer
Emeritus Fellow, UK Cochrane Centre
9 Park Crescent
London N3 2NL, UK
Tel: +44-20-8346-5470 
Fax: +44-20-8346-0407
mailto:andrew_herxheimer@compuserve.com

--
To send a message to AFRO-NETS, write to: afro-nets@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe afro-nets OR unsubscribe afro-nets
To contact a person, send a message to: afro-nets-help@usa.healthnet.org
Information and archives: http://www.afronets.org